Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Stability of Oseltamivir in Various Extemporaneous Liquid Preparations

Author(s):  Ford Stephen M, Kloesel Lawson G, Grabenstein John D

Issue:  Mar/Apr 2007 - Diabetes
View All Articles in Issue

Page(s):  164-176

Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Page 1
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Page 2
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Page 3
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Page 4
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Page 5
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Page 6
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Page 7
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Page 8
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Page 9
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Page 10
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Page 11
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Page 12
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Page 13

Download in electronic PDF format for $75

Abstract:  The purpose of this study was to determine the stability of oseltamivir, the active ingredient in Tamiflu, in contemporaneously compounded suspensions for a period of not less than 90 days. The suspension vehicles provided for the study were chosen because of ease of preparation, commercial availability, and palatability. Stability of the active ingredient was demonstrated for suspensions prepared in PCCA-Plus, PCCA Acacia, and 1% methylcellulose and was independent of storage temperature (tested temperatures were 2oC to 8oC and 25oC). A control sample of the commercial liquid form of Tamiflu was prepared, stored, and analyzed along with the samples prepared from the contents of capsules. There was no difference in the apparent stability of the two forms of the drug preparation.

Related Keywords: histamine 1 receptor inhibitor, H1 blocker, sedation, Stephen M Ford, PharmD, BCPS, BCOP, Lawson G Kloesel, RPh, BS Pharm, FIACP, John D Grabenstein, RPh, PhD, oseltamivir, antiviral agent, viral infection, virus, influenza, oral suspension vehicles, stability, storage, formulations

Related Categories: EXCIPIENTS, FORMULATIONS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, INFECTIOUS DISEASE, STORAGE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations
Ford Stephen M
, Kloesel Lawson G, Grabenstein John D
Mar/Apr 2007
Pg. 164-176

Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Chuong Monica
, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Nov/Dec 2019
Pg. 504-510

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution)
Voudrie Mark A II
, Allen D Brett
Jan/Feb 2010
Pg. 82-85

Oseltamivir Phosphate 15 mg/mL in SyrSpend SF
Allen Loyd V Jr
Jul/Aug 2018
Pg. 323

Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Polonini Hudson
, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Nov/Dec 2018
Pg. 516-526

Profile of a Practice: Stephen J. Newton, RPh, and PharmaTech Services, Inc., Avon, Colo.
Allen Loyd V Jr
Mar/Apr 2004
Pg. 107-109

Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design
Patel Gopesh
, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S
Jan/Feb 2021
Pg. 73-81

Oseltamivir 12-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2007
Pg. 332

PreScription: The International Academy of Compounding Pharmacists Remembers Evelyn Timmons, RPh, FIACP, and George Roentsch, RPh, FIACP
Karolchyk Scott
Jan/Feb 2012
Pg. 4

View Sample
Prevention Is the Best Medicine: Don J. Bottoni, RPh, FACA, FIACP
Bottoni Don J
Jan/Feb 2004
Pg. 22-27

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Stability of Extemporaneous Oral Ribavirin Liquid Preparation
Chan John P
, Tong Henry H Y, Chow Alber H L
Nov/Dec 2004
Pg. 486-488

Compounding for Skin Care: An Interview with John Hollis, RPh
Vail Jane
Mar/Apr 2002
Pg. 85-86

Compounded Pain Formulations: What is the Evidence?
Asbill Scott
, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014
Pg. 278-286

Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Polonini HC
, Loures S, Lima LC, Ferreira AO, Brandão MA
Mar/Apr 2016
Pg. 167-174

To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid
Chuong Monica C
, Taglieri Catherine A, Kerr Stephen G
Nov/Dec 2017
Pg. 500-512

Compounded Pain Formulations: What is the Evidence?
Asbill Scott
, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024
Pg. 100-109

Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
Trusley Craig
, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2008
Pg. 156-160

Pathophysiology and Management of Onychomycosis and Novel Approaches for Effective Transdermal Applications
Dharmian Jose Prakash
, Sathiyaseelan Iraniammal, Renganathan Akshaya, Mubees Alamaan Mohamed, Naser Mohammed Yasin Abdul, Ramkrishnan Prakash, Arumugam Somasundaram
Nov/Dec 2023
Pg. 494-502

Return to Top